Cellectis SA (CLLS)
3.44
+0.03
(+0.88%)
USD |
NASDAQ |
Apr 06, 16:00
3.44
0.00 (0.00%)
After-Hours: 16:07
Cellectis Total Assets (Quarterly) : 331.48M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 233.72M |
| EDAP TMS SA | 79.00M |
| Sanofi | -- |
| Akari Therapeutics Plc | 48.00M |
| Biodexa Pharmaceuticals Plc | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 255.58M |
| Shareholders Equity (Quarterly) | 75.90M |
| Debt to Equity Ratio | 1.580 |
| Current Ratio | 1.621 |
| Net Debt Paydown Yield | -0.32% |